Purchase Order HT942525PE039
Award Date 9/25/25
Potential Completion Date 12/22/30
Potential Value $379K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
ABER PROV GRD, MD 21010, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price purchase order awarded by the Defense Health Agency to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $197,939.00 contract is for a testing and maintenance agreement for two pathology instruments. The contract has no set-aside designation. Through prior prime contract awards, Illumina has provided sequencing systems and related goods and services to support genomic research and analysis across various federal agencies,...
- This is a definitive contract awarded by the Defense Health Agency (DHA) to Illumina, Inc., a for-profit biotechnology company that specializes in genetic sequencing and genomic analysis technologies. The contract is for preventative maintenance services for Illumina's NextSeq2000 sequencing platform, with a ceiling value of $379,842.00 and a completion date of September 11, 2029. The contract is a firm fixed-price arrangement, and no set-aside designation was used. Illumina has been awarded...
- This firm fixed-price Blanket Purchase Agreement (BPA) call contract was awarded by the Defense Health Agency to Illumina, Inc. for $435,072.04 to provide Illumina reagents, consumables, and equipment maintenance in support of the agency's operations. Under the terms of the contract, Illumina will deliver sequencing reagents, consumables, and maintenance services for Illumina sequencing equipment located in San Diego, California through September 2021. No set-aside provisions were applied to...
- This is a firm fixed price contract awarded by the Department of the Navy Bureau of Medicine and Surgery to Illumina, Inc. for the maintenance and repair of instruments and laboratory equipment. The $80,972.56 contract has an August 2022 completion date and does not utilize any set-aside provisions. Illumina is a for-profit manufacturer that has previously held prime contracts and subcontracts with various federal agencies, including the NIH, CDC, USDA, and VA, to provide genomic sequencing...
- This firm fixed-price purchase order was awarded by the National Institute on Aging, a civilian agency, to Illumina, Inc. for maintenance and repair support of three Illumina laboratory instruments used for genomic analysis and sequencing. The $205,890.00 contract covers support for the Illumina AutoLoader 2.x, LIHA 1, and iScan systems through December 16, 2025. Illumina is a manufacturer of sequencing and array-based solutions for genetic and genomic analysis, and has provided a range of...
- This is a firm fixed-price delivery order contract awarded by the Veterans Integrated Service Network 16 (VISN 16) of the U.S. Department of Veterans Affairs (VA) to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract, valued at $116,493.28, is for the preventive maintenance and repair of Illumina's equipment. The contract has an ultimate completion date of May 31, 2026. Illumina, headquartered in San Diego, California, is a specialized...
- The Defense Health Agency awarded a firm fixed-price purchase order to Illumina, Inc. on June 20, 2025, valued at $24,291.59, for deoxyribonucleic acid (DNA) sequencing reagent kits and Illumina DNA testing equipment designated for Walter Reed Medical Center in Bethesda, Maryland. The contract carries no set-aside designation, reflecting Illumina's specialized capabilities in genomic sequencing technologies. The purchase order is scheduled for completion by August 1, 2025, and represents a...
- Illumina, Inc. has been awarded a Blanket Purchase Agreement (BPA) call valued at $668,201.76 by the Defense Health Agency for the provision of reagents and service support plans. The award, executed on September 12, 2024, is structured as a firm fixed price contract with an ultimate completion date of September 30, 2025. Work will be performed at the contractor's facility in Takoma Park, Maryland. The contract was awarded without set-aside designation, reflecting Illumina's specialized...
- This is a firm fixed-price purchase order awarded by the Office of Acquisitions and Grants, a civilian agency, to Illumina, Inc., a manufacturer of genomic sequencing instruments and solutions. The contract is for $71,643.00 to provide service maintenance for an Illumina MiSeq sequencer. The award has no set-aside designation and the period of performance runs through June 10, 2024. Illumina has a history of providing sequencing systems and related services to various government agencies,...
- Illumina, Inc. has been awarded a delivery order valued at $34,745.64 for the renewal of service contract on Illumina Tecan equipment. This firm fixed-price contract, awarded on September 10, 2025, will continue through September 9, 2026, and is being funded by a civilian federal agency within the Northeast Area. The work will be performed at a facility in Calverton, Maryland. The contract does not utilize any set-aside designation, reflecting Illumina's specialized capabilities in providing...